# Effect of Intravenous or Intrathecal Dexmedetomidine on Bupivacaine Spinal Block in Lower Abdominal Surgery

> **NCT06654531** · PHASE2,PHASE3 · COMPLETED · sponsor: **Al-Azhar University** · enrollment: 50 (actual)

## Conditions studied

- Spinal Anesthetics Causing Adverse Effects in Therapeutic Use

## Interventions

- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT06654531
- **Lead sponsor:** Al-Azhar University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-02
- **Primary completion:** 2023-12-30
- **Final completion:** 2024-03-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06654531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06654531, "Effect of Intravenous or Intrathecal Dexmedetomidine on Bupivacaine Spinal Block in Lower Abdominal Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06654531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*